FMS vs. DVA

Last updated Apr 1, 2026

Compare and contrast key facts about Fresenius Medical Care AG & Co. KGaA (FMS) and DaVita Inc. (DVA).

Performance

FMS vs. DVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fresenius Medical Care AG & Co. KGaA (FMS) and DaVita Inc. (DVA). The values are adjusted to include any dividend payments, if applicable.

FMS vs. DVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FMS Fresenius Medical Care AG & Co. KGaA	-5.29%	8.11%	11.86%	30.88%	-48.42%	-20.28%	14.76%	15.62%	-37.60%	25.49%
DVA DaVita Inc.	35.28%	-24.03%	42.75%	40.30%	-34.36%	-3.10%	56.47%	45.80%	-28.78%	12.54%

Fundamentals

Market Cap FMS : $12.90B DVA : $13.54B
EPS FMS : $1.68 DVA : $9.14
PE Ratio FMS : 13.40 DVA : 16.82
PEG Ratio FMS : 0.49 DVA : 3.12
PS Ratio FMS : 0.67 DVA : 0.92
Total Revenue (TTM) FMS : $19.63B DVA : $13.28B
Gross Profit (TTM) FMS : $5.03B DVA : $4.21B
EBITDA (TTM) FMS : $3.34B DVA : $2.71B

Returns By Period

In the year-to-date period, FMS achieves a -5.29% return, which is significantly lower than DVA's 35.28% return. Over the past 10 years, FMS has underperformed DVA with an annualized return of -4.68%, while DVA has yielded a comparatively higher 7.59% annualized return.

FMS

• 1D: 1.58%
• 1M: -3.84%
• YTD: -5.29%
• 6M: -14.32%
• 1Y: -6.90%
• 3Y*: 4.83%
• 5Y*: -6.94%
• 10Y*: -4.68%

DVA

• 1D: 0.87%
• 1M: -1.67%
• YTD: 35.28%
• 6M: 15.67%
• 1Y: 0.47%
• 3Y*: 23.74%
• 5Y*: 7.83%
• 10Y*: 7.59%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FMS vs. DVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FMS

FMS Risk / Return Rank: 31
FMS Sharpe Ratio Rank: 31
FMS Sortino Ratio Rank: 27
FMS Omega Ratio Rank: 27
FMS Calmar Ratio Rank: 35
FMS Martin Ratio Rank: 35

DVA

DVA Risk / Return Rank: 41
DVA Sharpe Ratio Rank: 42
DVA Sortino Ratio Rank: 38
DVA Omega Ratio Rank: 37
DVA Calmar Ratio Rank: 44
DVA Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FMS vs. DVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fresenius Medical Care AG & Co. KGaA (FMS) and DaVita Inc. (DVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FMS	DVA	Difference
Sharpe ratio Return per unit of total volatility	-0.24	0.01	-0.25
Sortino ratio Return per unit of downside risk	-0.13	0.31	-0.44
Omega ratio Gain probability vs. loss probability	0.98	1.04	-0.06
Calmar ratio Return relative to maximum drawdown	-0.23	0.07	-0.30
Martin ratio Return relative to average drawdown	-0.41	0.14	-0.56
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FMS vs. DVA - Sharpe Ratio Comparison

The current FMS Sharpe Ratio is -0.24, which is lower than the DVA Sharpe Ratio of 0.01. The chart below compares the historical Sharpe Ratios of FMS and DVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FMS	DVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.24	0.01	-0.25
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.22	0.22	-0.44
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.16	0.23	-0.39
Sharpe Ratio (All Time) Calculated using the full available price history	0.12	0.31	-0.19

Correlation

The correlation between FMS and DVA is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FMS vs. DVA - Dividend Comparison

FMS's dividend yield for the trailing twelve months is around 3.49%, while DVA has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FMS Fresenius Medical Care AG & Co. KGaA	3.49%	3.30%	2.80%	2.97%	4.34%	2.57%	1.72%	1.78%	1.95%	0.70%	0.74%	0.71%
DVA DaVita Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

FMS vs. DVA - Drawdown Comparison

The maximum FMS drawdown since its inception was -77.59%, smaller than the maximum DVA drawdown of -92.91%. Use the drawdown chart below to compare losses from any high point for FMS and DVA.

Drawdown Indicators

	FMS	DVA	Difference
Max Drawdown Largest peak-to-trough decline	-77.59%	-92.91%	+15.32%
Max Drawdown (1Y) Largest decline over 1 year	-28.42%	-33.21%	+4.79%
Max Drawdown (5Y) Largest decline over 5 years	-68.85%	-51.10%	-17.75%
Max Drawdown (10Y) Largest decline over 10 years	-75.61%	-51.10%	-24.51%
Current Drawdown Current decline from peak	-53.37%	-13.34%	-40.03%
Average Drawdown Average peak-to-trough decline	-23.61%	-20.14%	-3.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.54%	16.25%	-0.71%

Volatility

FMS vs. DVA - Volatility Comparison

Fresenius Medical Care AG & Co. KGaA (FMS) and DaVita Inc. (DVA) have volatilities of 6.26% and 6.58%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FMS	DVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.26%	6.58%	-0.32%
Volatility (6M) Calculated over the trailing 6-month period	20.89%	28.09%	-7.20%
Volatility (1Y) Calculated over the trailing 1-year period	29.29%	36.25%	-6.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.41%	35.62%	-4.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	29.01%	33.76%	-4.75%

Financials

FMS vs. DVA - Profitability Comparison

The chart below illustrates the profitability comparison between Fresenius Medical Care AG & Co. KGaA and DaVita Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

FMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Fresenius Medical Care AG & Co. KGaA reported a gross profit of 1.39B and revenue of 5.07B. Therefore, the gross margin over that period was 27.4%.

DVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, DaVita Inc. reported a gross profit of 1.02B and revenue of 3.26B. Therefore, the gross margin over that period was 31.4%.

FMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Fresenius Medical Care AG & Co. KGaA reported an operating income of 594.00M and revenue of 5.07B, resulting in an operating margin of 11.7%.

DVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, DaVita Inc. reported an operating income of 423.00M and revenue of 3.26B, resulting in an operating margin of 13.0%.

FMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Fresenius Medical Care AG & Co. KGaA reported a net income of 327.00M and revenue of 5.07B, resulting in a net margin of 6.5%.

DVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, DaVita Inc. reported a net income of 216.00M and revenue of 3.26B, resulting in a net margin of 6.6%.